Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review

202228 citationsReviewhybrid Open Access

Authors

Zijun Wang · China International Science and Technology Cooperation

Siya Zhao · Lanzhou University

Yuyi Tang · China International Science and Technology Cooperation

Zhili Wang · China International Science and Technology Cooperation

Qianling Shi · Lanzhou University

Xiangyang Dang · China International Science and Technology Cooperation

Lidan Gan

Abstract

• Overall, the current evidence cannot adequately demonstrate the effectiveness and safety of using remdesivir, glucocorticoids, and IVIG in treating children and adolescents with COVID-19 or MIS-C. • We are calling for the publication of high-quality clinical trials and provide substantial evidence for the development of guidelines.

Topics & Keywords

Kawasaki Disease and Coronary Complications COVID-19 Clinical Research Studies COVID-19 Impact on Reproduction

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Journal of Pediatrics

Volume 181, Issue 5, pp. 2135-2146

DOI: 10.1007/s00431-022-04388-w

Field-Weighted Citation Impact: 6.10